MARÍA ALBA
GALDÓN SANZ-PASTOR
Profesora asociada de Ciencias de la Salud
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (4)
2024
-
Are New Ultra-Rapid-Acting Insulins Associated with Improved Glycemic Control and Reduced Hypoglycemia in Comparison to Conventional Rapid-Acting Insulins for Individuals with Type 1 and Type 2 Diabetes? A Systematic Review and Meta-Analysis
Diabetes Technology and Therapeutics
-
Current barriers to initiating insulin therapy in individuals with type 2 diabetes
Frontiers in Endocrinology, Vol. 15
-
Prediabetes and Cardiometabolic Risk: The Need for Improved Diagnostic Strategies and Treatment to Prevent Diabetes and Cardiovascular Disease
Biomedicines, Vol. 12, Núm. 2
2023
-
Effectiveness and Tolerability of the Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily in Patients with Type 2 Diabetes in Real Life: The INTENSIFY Study
Journal of Clinical Medicine, Vol. 12, Núm. 13